A metal-based tumour necrosis factor-alpha converting enzyme inhibitor. (Q38917646)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25610924%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

title

A metal-based tumour necrosis factor-alpha converting enzyme inhibitor (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25610924%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

0 references

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25610924%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Dik-Lung Ma

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25610924%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

Li-Juan Liu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25610924%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Lihua Lu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25610924%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Bingyong He

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25610924%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Chun-Yuen Wong

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25610924%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Chung-Hang Leung

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25610924%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

language of work or name

English

0 references

publication date

1 March 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25610924%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

published in

Chemical Communications

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25610924%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

volume

51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25610924%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

issue

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25610924%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

3973-3976

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25610924%20AND%20SRC:MED&resulttype=core&format=json

TNF-mediated inflammatory disease.

28 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC4CC09251A

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4CC09251A

Cytokines in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4CC09251A

Suramin promotes recovery from renal ischemia/reperfusion injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4CC09251A

Solvent Selection for Insoluble Ligands, a Challenge for Biological Assay Development: A TNF-α/SPD304 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4CC09251A

Structure-based discovery of natural-product-like TNF-α inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4CC09251A

A metal-based inhibitor of tumor necrosis factor-α.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4CC09251A

Safety and steroid-sparing experience using infliximab for Crohn's disease at a pediatric inflammatory bowel disease center

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4CC09251A

Tumor necrosis factor signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4CC09251A

Anti-TNF-alpha therapies: the next generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4CC09251A

A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4CC09251A

TACE and other ADAM proteases as targets for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4CC09251A

ADAMs: key components in EGFR signalling and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4CC09251A

Crystal structure of the catalytic domain of human tumor necrosis factor-alpha-converting enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4CC09251A

Targeting TACE-dependent EGFR ligand shedding in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4CC09251A

Multiple acquired renal carcinoma tumor capabilities abolished upon silencing of ADAM17.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4CC09251A

TACE is required for the activation of the EGFR by TGF-alpha in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4CC09251A

Role of ADAMs in endothelial cell permeability: cadherin shedding and leukocyte rolling

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4CC09251A

L-selectin: mechanisms and physiological significance of ectodomain cleavage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4CC09251A

Effects of TNFalpha-converting enzyme inhibition on amyloid beta production and APP processing in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4CC09251A

ADAMs family members as amyloid precursor protein alpha-secretases

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4CC09251A

Current perspective of TACE inhibitors: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4CC09251A

The clinical potential of matrix metalloproteinase inhibitors in the rheumatic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4CC09251A

Drug insight: tumor necrosis factor-converting enzyme as a pharmaceutical target for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4CC09251A

Novel TACE inhibitors in drug discovery: a review of patented compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4CC09251A

New trends for metal complexes with anticancer activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4CC09251A

Targeting nucleus DNA with a cyclometalated dipyridophenazineruthenium(II) complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4CC09251A

From conventional to unusual enzyme inhibitor scaffolds: the quest for target specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4CC09251A

Metal complexes in medicine with a focus on enzyme inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4CC09251A

Application of mass spectrometric techniques to delineate the modes-of-action of anticancer metallodrugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4CC09251A

On the biological properties of alkynyl phosphine gold(I) complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4CC09251A

Enhanced Cytotoxicity through Conjugation of a "Clickable" Luminescent Re(I) Complex to a Cell-Penetrating Lipopeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4CC09251A

Luminescent properties of ruthenium(II) complexes with sterically expansive ligands bound to DNA defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4CC09251A

Rational design of a structural framework with potential use to develop chemical reagents that target and modulate multiple facets of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4CC09251A

Bioactive luminescent transition-metal complexes for biomedical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4CC09251A

Group 9 organometallic compounds for therapeutic and bioanalytical applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4CC09251A

Direct activation of TACE-mediated ectodomain shedding by p38 MAP kinase regulates EGF receptor-dependent cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4CC09251A

p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4CC09251A

Group 9 metal-based inhibitors of β-amyloid (1–40) fibrillation as potential therapeutic agents for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4CC09251A

21 January 2018

Identifiers

DOI

10.1039/C4CC09251A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25610924%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference